The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.

Clin Exp Immunol. 2007 Feb;147(2):306-12.
The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.
Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, Grimbacher B; ESID Registry Working Party.
Source

Division of Rheumatology and Clinical Immunology, University Hospital Freiburg, Germany.
Abstract

Because primary immunodeficiencies (PI) are rare diseases, transnational studies are essential to maximize the scientific outcome and lead to improved diagnosis and therapy. Immunologists in Europe have united to determine the prevalence of PI in Europe and to establish and evaluate harmonized guidelines for the diagnosis and treatment of PI as well as to improve the awareness of PI in Europe. In order to achieve this aim we have developed an internet-based database for clinical and research data on patients with PI. This database forms the platform for studies of demographics, the development of new diagnostic and therapeutic strategies and the identification of novel disease-associated genes. The database is completely secure, while providing access to researchers via a standard browser using password and encrypted log-in sessions and conforms to all European and national ethics and data protection guidelines. So far 2386 patients have been documented by 35 documenting centres in 20 countries. Common variable immunodeficiency (CVID) is the most common entity, accounting for almost 30% of all entries. First statistical analyses on the quality of life of patients show the advantages of immunoglobulin replacement therapy, at the same time revealing a mean diagnostic delay of over 4 years. First studies on specific questions on selected PID are now under way. The platform of this database can be used for any type of medical condition.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100